Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | HPGD | P15428 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7769437 | 0.86 | ALDH1A1 (0.54) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL14369503 | 0.86 | ALDH1A1 (0.58) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL22203030 | 0.84 | MEN1 (0.46) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL10076741 | 0.84 | L3MBTL1 (0.45) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL3686150 | 0.84 | ALDH1A1 (0.51) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL15907989 | 0.84 | ALDH1A1 (0.48) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL19695817 | 0.83 | ALDH1A1 (0.54) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL2633144 | 0.81 | ALDH1A1 (0.44) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL13221517 | 0.81 | ALDH1A1 (0.42) | ALDH1A1HPGDMEN1KMT2AMAPT | |
| SCHEMBL27609104 | 0.81 | GSK3B (0.44) | ALDH1A1HPGDMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3628 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028938-A | Pharmaceutical combination comprising an anti-CD 37 antibody maytansinoid conjugate and a BCL2 inhibitor or PI3K inhibitor | 德彪药业国际股份公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4678240-A2 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | Hangzhou Dac Biotech Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| EP-3319936-B1 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | HANGZHOU DAC BIOTECH CO LTD (CN) | 2025-12-17 | — | — | EP | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4592311-A2 | ANTIBODIES | Lonza Ltd (CH) | 2025-07-30 | — | — | EP | claimed |
| US-12364767-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-07-22 | — | — | US | claimed |
| WO-2025151464-A1 | ALPHA-PARTICLE RADIONUCLIDE-ANTIBODY CONJUGATES FOR TREATMENT OF SOLID TUMORS | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-07-17 | — | — | WO | claimed |
| US-20110195021-A1 | CD20 ANTIBODIES AND USES THEREOF | IMMUNOGEN INC. (US) | 2011-08-11 | — | — | US | claimed |
| US-7989598-B2 | Antibodies; tissue-targeted therapy; for treatment of tumors, autoimmune diseases, graft rejections, graft versus host disease, viral infections, parasite infections | IMMUNOGEN INC. (US) | 2011-08-02 | — | — | US | claimed |
| US-20080171856-A1 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES | IMMUNOGEN, INC. (US) | 2008-07-17 | — | — | US | claimed |
| US-20080145374-A1 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES | IMMUNOGEN, INC. (US) | 2008-06-19 | — | — | US | claimed |
| US-20080114153-A1 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES | IMMUNOGEN. INC. (US) | 2008-05-15 | — | — | US | claimed |
| EP-1689846-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | Immunogen, Inc. (US) | 2006-08-16 | — | — | EP | claimed |
| EP-1328811-B1 | HCV MOSAIC ANTIGEN COMPOSITION | MEDMIRA INC (CA) | 2005-08-31 | — | — | EP | claimed |
| US-20050169933-A1 | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates | IMMUNOGEN, INC. | 2005-08-04 | — | — | US | claimed |
| WO-2005037992-A2 | METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES, AND METHODS OF MAKING SAID CONJUGATES | IMMUNOGEN, INC. (US) | 2005-04-28 | — | — | WO | claimed |
| WO-1994000600-A1 | SOLID SUPPORTS FOR NUCLEIC ACID HYBRIDIZATION ASSAYS | MICROPROBE CORPORATION (US) | 1994-01-06 | — | — | WO | claimed |